10:39 AM EDT, 07/30/2025 (MT Newswires) -- Becton Dickinson ( BDX ) said its BD Veritor System for COVID-19 received FDA 510(k) clearance, transitioning the test to complete regulatory approval from Emergency Use Authorization.

The newly cleared version will begin replacing the current product starting in the early autumn, the company said Wednesday in a statement.

The test, designed for clinics, urgent care facilities and retail health sites, delivers digital results in 15 minutes and detects COVID-19 antigens from nasal swab specimens within six days of symptom onset.

Price: 182.07, Change: -0.31, Percent Change: -0.17